Asish Xavier, vice president of venture investments at JJDC, expresses cautious optimism for the biotech sector's recovery, predicting an increase in funding and IPOs as interest rates decline. He emphasizes the importance of addressing unmet needs and maintaining focus on critical milestones for startups, while highlighting the value of pharmaceutical partnerships in enhancing company valuations.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.